Both acute and prolonged administration of EPO reduce cerebral and systemic vascular conductance in humans

Cerebral Artery Dilatation Maintains Cerebral Oxygenation at Extreme Altitude and in Acute Hypoxia—An Ultrasound and MRI Study

(2011) Mark H Wilson et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Effects of erythropoietin administration on cerebral metabolism and exercise capacity in men

(2010) P. Rasmussen et al.   JOURNAL OF APPLIED PHYSIOLOGY

Regulation of erythropoietin production

(2010) Wolfgang Jelkmann   JOURNAL OF PHYSIOLOGY-LONDON

Effects of recombinant human erythropoietin in normal humans

(2010) Carsten Lundby et al.   JOURNAL OF PHYSIOLOGY-LONDON

Arterial Hypertension Induced by Erythropoietin and Erythropoiesis-Stimulating Agents (ESA)

(2009) R. Krapf et al.   Clinical Journal of the American Society of Nephrology

Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial

(2009) Ming-Yuan Tseng et al.   JOURNAL OF NEUROSURGERY

Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke

(2009) Hannelore Ehrenreich et al.   STROKE

Does recombinant human Epo increase exercise capacity by means other than augmenting oxygen transport?

(2008) C. Lundby et al.   JOURNAL OF APPLIED PHYSIOLOGY

Elevation in cerebral blood flow velocity with aerobic fitness throughout healthy human ageing

(2008) Philip N. Ainslie et al.   JOURNAL OF PHYSIOLOGY-LONDON